Research ArticleResearch Article

Kaposiform Hemangioendothelioma: Case Report and Literature Review

Gang Zhou, Shuhua Yang, Xiu Nie, Jingyuan Du, Jin Li, Jianxiang Liu, Renhao Ze and Yu He
Chinese Journal of Clinical Oncology August 2007, 4 (4) 288-292; DOI: https://doi.org/10.1007/s11805-007-0289-z

REFERENCES

  1. ↵
    1. Weiss SW,
    2. Goldblum JR
    . Enzinger and Weiss’s Soft Tissue Tumors, 4th Ed. Philadelphia: Mosby-Harcourt Brace 2001.
  2. ↵
    1. Zukerberg LR,
    2. Nickoloff BJ,
    3. Weiss SW
    . Kaposiform hemangioendothelioma of infancy and childhood. An aggressive neoplasm associated with Kasabach-Merritt syndrome and lymphangiomatosis. Am J Surg Pathol 1993;17:321–328.
    OpenUrlCrossRefPubMedWeb of Science
  3. ↵
    1. Gruman A,
    2. Liang MG,
    3. Mulliken JB, et al.
    Kaposiform hemangioendothelioma without Kasabach-Merritt phenomenon. J Am Acad Dermatol 2005;52:616-622.
    OpenUrlCrossRefPubMed
  4. ↵
    1. Lyons LL,
    2. North PE,
    3. Mac-Moune Lai, et al.
    Kaposiform hemangioendothelioma: a study of 33 cases emphasizing its pathologic, immunophenotypic, and biologic uniqueness from juvenile hemangioma. Am J Surg Pathol 2004;28:559–568.
    OpenUrlCrossRefPubMedWeb of Science
  5. ↵
    1. Vin-Christian K,
    2. McCalmont TH,
    3. Frieden IJ
    . Kaposiform hemangioendothelioma. An aggressive, locally invasive vascular tumor that can mimic hemangioma of infancy. Arch Dermatol 1997;133:1573-1578.
    OpenUrlCrossRefPubMedWeb of Science
  6. ↵
    1. Mentzel T
    . Hemangioendotheliomas--evolution of a concept of a heterogeneous group of vascular neoplasms Verh Dtsch Ges Pathol 1998;82:99-111.
    OpenUrlPubMed
  7. ↵
    1. Drolet BA,
    2. Esterly NB,
    3. Frieden IJ
    . Hemangiomas in children. N Engl J Med 1999;341:173-181.
    OpenUrlCrossRefPubMedWeb of Science
  8. ↵
    1. el-Dessouky M,
    2. Azmy AF,
    3. Raine PA, et al.
    Kasabach-Merritt syndrome. J Pediatr Surg 1988;23:109-111.
    OpenUrlCrossRefPubMedWeb of Science
  9. ↵
    1. Sarkar M,
    2. Mulliken JB,
    3. Kozakewich HP, et al.
    Thrombocytopenic coagulopathy (Kasabach-Merritt phenomenon) is associated with Kaposiform hemangioendothelioma and not with common infantile hemangioma. Plast Reconstr Surg 1997;100:1377-1386.
    OpenUrlCrossRefPubMed
  10. ↵
    1. Mentzel T,
    2. Mazzoleni G,
    3. Dei Tos AP, et al.
    Kaposiform hemangioendothelioma in adults. Clinicopathologic and immunohistochemical analysis of three cases. Am J Clin Pathol 1997;108:450-455.
    OpenUrlCrossRefPubMed
  11. ↵
    1. Chang JM,
    2. Kwon BJ,
    3. Han MH, et al.
    Kaposiform hemangioendothelioma arising from the internal auditory canal. AJNR Am J Neuroradiol 2006;27:931-933.
    OpenUrlPubMed
  12. ↵
    1. Bienaime A,
    2. Rojat-Habib MC,
    3. Hesse S, et al.
    Giant vascular tumour in an adult: tufted angioma or kaposiform hemangioendothelioma. Ann Dermatol Venereol 2006;133:553-556.
    OpenUrlPubMed
  13. ↵
    1. Mendoza AA,
    2. Lourdes TS,
    3. Sanz CR,
    4. Maldorado RR
    . Histopathology of vascular lesions found in Kasabach-Merritt Syndrome: Review based on 13 Cases. Ped Dev Path 2000;3;556–560.
    OpenUrl
  14. ↵
    1. North PE,
    2. Waner M,
    3. Mizeracki A, et al.
    GLUT1: a newly discovered immunohistochemical marker for juvenile hemangiomas. Hum Pathol 2000;31:11–22.
    OpenUrlCrossRefPubMedWeb of Science
  15. ↵
    1. Folpe AL,
    2. Veikkola T,
    3. Valtola R, et al.
    Vascular endothelial growth factor receptor-3 (VEGFR-3): a marker of vascular tumors with presumed lymphatic differentiation, including Kaposi’s sarcoma, kaposiform and Dabskatype hemangioendotheliomas, and a subset of angiosarcomas. Mod Pathol 2000;13:180–185.
    OpenUrlCrossRefPubMedWeb of Science
  16. ↵
    1. Debelenko LV,
    2. Perez-Atayde AR,
    3. Mulliken JB, et al.
    D2-40 immunohistochemical analysis of pediatric vascular tumors reveals positivity in kaposiform hemangioendothelioma. Mod Pathol 2005;18:1454-1460.
    OpenUrlCrossRefPubMedWeb of Science
  17. ↵
    1. Arai E,
    2. Kuramochi A,
    3. Tsuchida T, et al.
    Usefulness of D2-40 immunohistochemistry for differentiation between kaposiform hemangioendothelioma and tufted angioma. J Cutan Pathol 2006;33:492-497.
    OpenUrlPubMed
  18. ↵
    1. Kasabach H,
    2. Merritt K
    . Capillary hemangioma with extensive purpura: report of a case. Am J Dis Child 1940;59:1063–1070.
    OpenUrlCrossRef
  19. ↵
    1. Enjolras O,
    2. Wassef M,
    3. Mazoyer E, et al.
    Infants with Kasabach-Merritt syndrome do not have “true” hemangiomas. J Pediatr 1997;130:631–640.
    OpenUrlCrossRefPubMedWeb of Science
  20. ↵
    1. Tsang WY,
    2. Chan JK
    . Kaposi-like infantile hemangioendothelioma: a distinctive vascular neoplasm of the retroperitoneum. Am J Surg Pathol. 1991; 15(10) :982-9.
    OpenUrlCrossRefPubMedWeb of Science
  21. ↵
    1. Cheuk W,
    2. Wong KO,
    3. Wong CS, et al.
    Immunostaining for human herpesvirus 8 latent nuclear antigen-1 helps distinguish Kaposi sarcoma from its mimickers. Am J Clin Pathol 2004;121:335-342.
    OpenUrlCrossRefPubMed
  22. ↵
    1. Brasanac D,
    2. Janic D,
    3. Boricic I, et al.
    Retroperitoneal kaposiform hemangioendothelioma with tufted angioma-like features in an infant with Kasabach-Merritt syndrome. Pathol Int 2003;53:627-631.
    OpenUrlCrossRefPubMed
  23. ↵
    1. Chu CY,
    2. Hsiao CH,
    3. Chiu HC
    . Transformation between kaposiform hemangioendothelioma and tufted angioma. Dermatology 2003;206:334-337
    OpenUrlCrossRefPubMedWeb of Science
  24. ↵
    1. Jones EW,
    2. Orkin M
    . Tufted angioma (angioblastoma). A benign progressive angioma, not to be confused with Kaposi’s sarcoma or low-grade angiosarcoma. J Am Acad Dermatol 1989;20:214-225.
    OpenUrlCrossRefPubMedWeb of Science
  25. ↵
    1. Enjolras O,
    2. Mulliken JB,
    3. Wassef M, et al.
    Residual lesions after Kasabach-Merritt phenomenon in 41 patients. J Am Acad Dermatol 2000;42:225–235.
    OpenUrlCrossRefPubMedWeb of Science
  26. ↵
    1. Hu B,
    2. Lachman R,
    3. Phillips J, et al.
    Kasabach-Merritt syndrome associated kaposiform hemangioendothelioma successfully treated with cyclophosphamide, vincristine, and actinomycin D. J Pediatr Hematol Oncol 1998;20:567–569.
    OpenUrlCrossRefPubMedWeb of Science
  27. ↵
    1. Hauer J,
    2. Graubner U,
    3. Konstantopoulos N, et al.
    Effective treatment of kaposiform hemangioendotheliomas associated with Kasabach-Merritt phenomenon using four-drug regimen. Pediatr Blood Cancer 2006;[Epub ahead of print].
  28. ↵
    1. DeFatta RJ,
    2. Verret DJ,
    3. Adelson RT, et al.
    Kaposiform Hemangioendothelioma: case report and literature review. Laryngoscope 2005;1150:1789-1792.
    OpenUrl
  29. ↵
    1. Blei F,
    2. Karp N,
    3. Rofsky N, et al.
    Successful multimodal therapy for kaposiform hemangioendothelioma complicated by Kasabach-Merritt phenomenon: case report and review of the literature. Pediatr Hematol Oncol 1999;16:373-374.
    OpenUrlPubMed
Back to top

In this issue

Print
Download PDF
Email Article
Citation Tools

Jump to section

Keywords